Literature DB >> 8386760

Technetium-99m(V)dimercaptosuccinic acid uptake in intra-abdominal massive deposit of amyloid protein.

H Kobayashi1, H Sakahara, T Itoh, T Kudoh, T Takagi, K Shibuya, S Nomura, M Hosono, K Endo, J Konishi.   

Abstract

Technetium-99m(V)dimercaptosuccinic acid (DMSA) scintigraphy was performed in two patients with pathologically confirmed primary amyloidosis. Both patients had tumor-like deposits of AL-type amyloid in the abdomen. Marked uptake of the tracer by the amyloid deposits was noted. Technetium-99m-(V)DMSA scintigraphy appears to be useful in detecting the distribution of amyloid deposits and in determining the appropriate site for biopsy.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8386760

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  5 in total

Review 1.  Diffuse mesenteric amyloidosis.

Authors:  V Mohan; J A Kemp; H E Lewine; M Rabin; M L Goldstein; F A Farraye
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

2.  In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid.

Authors:  A S Lam; M R Puncher; P J Blower
Journal:  Eur J Nucl Med       Date:  1996-12

3.  Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin.

Authors:  C Aprile; G Marinone; R Saponaro; C Bonino; G Merlini
Journal:  Eur J Nucl Med       Date:  1995-12

Review 4.  Nuclear imaging in cardiac amyloidosis.

Authors:  A W J M Glaudemans; R H J A Slart; C J Zeebregts; N C Veltman; R A Tio; B P C Hazenberg; R A J O Dierckx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-21       Impact factor: 9.236

5.  Functional imaging techniques for evaluation of sarcomas.

Authors:  Rodney J Hicks
Journal:  Cancer Imaging       Date:  2005-06-21       Impact factor: 3.909
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.